comparemela.com

Maria Reig News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Fostrox/Lenvatinib Combination Displays Efficacy, Tolerability in Pretreated HCC

Fostroxacitabine bralpamide plus lenvatinib displayed preliminary efficacy with a tolerable safety profile in patients with hepatocellular carcinoma.

Fostrox + Lenvima shows further improved response rates and time to progression in advanced liver cancer (HCC) at ASCO GI Symposium

vimarsana © 2020. All Rights Reserved.